Novonesis Plant Biosolutions A/S: Financial statements 2017
CVR: 30919246
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Novonesis Plant Biosolutions A/S (CVR 30919246) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 354,942,745 and a net result of DKK 47,102,055 compared with DKK -58,817,007 the year before. That is an increase of 0.8% compared with the year before. The profit margin was 13.3%. Equity in the 2017 report amounted to DKK 847,530,309. The solvency ratio was 41.4%.
- Revenue
- DKK 354,942,745
- Gross Profit
- DKK 359,839,830
- Profit/Loss
- DKK 47,102,055
- Equity
- DKK 847,530,309
- Total Assets
- DKK 2,046,544,870
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 354.9M | 359.8M | 47.1M | 847.5M | - |
| 2016 | 352.1M | 320.8M | -58.8M | 974.4M | - |
| 2015 | - | 365.9M | 83.7M | 1.4B | - |
Official annual report
Keep an eye on Novonesis Plant Biosolutions A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of August 10, 2017, Randi Camilla Kinch Jensen has joined the board of directors of Novonesis Plant Biosolutions A/S.
As of August 10, 2017, Benny Dalgaard Loft has left the board of directors of Novonesis Plant Biosolutions A/S.
Novonesis Plant Biosolutions A/S has published its annual report for 2016. Revenue came to DKK 352,106,958, and the net result was DKK -58,817,007.
As of March 1, 2017, Tina Sejersgård Fanø has joined the board of directors of Novonesis Plant Biosolutions A/S.
As of March 1, 2017, Thomas Videbæk has left the board of directors of Novonesis Plant Biosolutions A/S.
About Novonesis Plant Biosolutions A/S
Novonesis Plant Biosolutions A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2007. The company is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. The company was previously named NOVOZYMES BIOAG A/S and NOVOZYMES BIOLOGICALS HOLDING A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported revenue of DKK 126,088,828 and a net result of DKK 520,581,561 compared with DKK 403,926,577 the year before. Equity in the 2025 report amounted to DKK 853,779,346.
